Form 4: Emergent BioSolutions Executive Sells Shares to Cover Taxes

William Hartzel, SVP of Bioservices at Emergent BioSolutions, sold 632 shares of common stock to cover tax obligations.

Summary

• William Hartzel, a Senior Vice President at Emergent BioSolutions, sold 632 shares of the company's common stock on November 11, 2024.
• The sale was executed at a price of $11.97 per share.
• This transaction was conducted to cover tax obligations related to stock awards.
• Following the transaction, Hartzel directly owns 47,475 shares of Emergent BioSolutions stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment towards the company's prospects.

Industry Context

This is a routine transaction for executives to manage their tax liabilities related to stock-based compensation. It is common for executives to sell shares to cover taxes.

Comparison to Industry Standards

• Executive stock sales for tax purposes are a common practice across publicly traded companies.
• The number of shares sold is relatively small compared to the total holdings of the executive, suggesting this is a routine tax-related transaction rather than a significant change in sentiment.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders as it is a routine sale for tax purposes.

Key Dates

Keywords

Emergent BioSolutions, insider trading, stock sale, Form 4, executive, bioservices, tax obligations